Last reviewed · How we verify
NCT06944340
Evaluating the Impact of WHO Trauma Care Checklist on Clinical Outcome of Patients
NA trial testing WHO Trauma Care Checklist in Trauma Related Injuries in 60 participants. Completed in 1 September 2025.
15 August 2025
Quick facts
| Lead sponsor | Khyber Teaching Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 26 April 2025 |
| Primary completion | 15 August 2025 |
| Estimated completion | 1 September 2025 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- WHO Trauma Care Checklist
Conditions studied
- Trauma Related Injuries — all drugs for Trauma Related Injuries →
- Trauma — all drugs for Trauma →
Sponsor
Khyber Teaching Hospital
Who can join
Adults 18 to 60, any sex, with Trauma Related Injuries or Trauma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is being conducted at the Department of Trauma and Orthopedics at Khyber Teaching Hospital, Peshawar. It will test whether using the World Health Organization (WHO) Trauma Care Checklist can help improve the care and recovery of patients who have experienced physical injuries (trauma). Injuries are a major cause of death and disability, especially in countries like Pakistan. When someone is seriously injured, doctors must act quickly and carefully to save lives and prevent long-term problems. Checklists are simple tools that help healthcare providers make sure nothing is missed during treatment. In this study, adult trauma patients will be randomly divided into two groups: One group will receive the standard trauma care (Group A). The other group will receive trauma care with the help of the WHO checklist (Group B). Doctors will compare the outcomes of both groups by looking at things like pain levels, injury severity, recovery progress, complications (like infections or organ problems), and overall satisfaction. The goal is to see if the checklist makes a meaningful difference in patient recovery and safety.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06944340
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Khyber Teaching Hospital trials
Trials by the same sponsor.
- NCT07464717 — Standard Versus Mini Percutaneous Nephrolithotomy for Renal Stones · NA · completed
- NCT07090928 — Effectiveness of Per-Operative Bupivicaine in Reducing Postoperative Pain at Port Site and Improving Mobility in Knee Ar · Phase 4 · not yet recruiting
- NCT06976424 — Comparison of a Face Cream Plus a Laser Procedure and Face Cream Alone in Treatment of Excessive Face Hairs in Female · Phase 4 · recruiting
- NCT07016360 — Comparison of Effectiveness of Topical Retinoids Versus Liquid Nitrogen in Treatment of Plantar Warts(Viral Infection) · Phase 4 · recruiting
- NCT07130864 — Early vs Late Laparoscopic Cholecystectomy After Common Bile Duct Stones Clearance Through Ercp. · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06944340 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Khyber Teaching Hospital
- Last refreshed: 17 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06944340.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing